Paul L. Debbage
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
- Biomaterials 13
- Nanoparticle-Based Drug Delivery 13
-
- Glycosylation and Glycoproteins Research 10
- Angiogenesis and VEGF in Cancer 5
- Co-authors
- Werner Rudolf Jaschke (9 shared papers)Ira Skvortsova (10 shared papers)Sergej Skvortsov (10 shared papers)Peter H. Lukas (10 shared papers)Christian Kremser (16 shared papers)Vinod Kumar (1 shared paper)Hans‐Joachim Gabius (7 shared papers)Peter Hutzler (6 shared papers)
- Journals
- Histochemistry and Cell Biology (12 papers)Radiotherapy and Oncology (2 papers)Seminars in Cancer Biology (2 papers)Molecular Imaging and Biology (2 papers)Acta Histochemica (2 papers)
- Partner nations
- AustriaGermanySwitzerland
In The Last Decade
Paul L. Debbage
74 papers receiving 2k citations
Peers
Comparison fields: 5 of 114
- Biomaterials 283
- Drug Discovery 5
- Pharmaceutical Science 112
- Structural Biology 34
- Otorhinolaryngology 62
Countries citing papers authored by Paul L. Debbage
This map shows the geographic impact of Paul L. Debbage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul L. Debbage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul L. Debbage more than expected).
Fields of papers citing papers by Paul L. Debbage
This network shows the impact of papers produced by Paul L. Debbage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul L. Debbage. The network helps show where Paul L. Debbage may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul L. Debbage, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 202 | |
| 2 | 2008 | 187 | |
| 3 | 2004 | 124 | |
| 4 | 2015 | 120 | |
| 5 | 2014 | 91 | |
| 6 | 2000 | 79 | |
| 7 | 1998 | 70 | |
| 8 | 2014 | 66 | |
| 9 | 2000 | 60 | |
| 10 | 2010 | 56 | |
| 11 | 2006 | 54 | |
| 12 | 2011 | 53 | |
| 13 | 2002 | 44 | |
| 14 | 2006 | 41 | |
| 15 | 2010 | 41 | |
| 16 | 2005 | 39 | |
| 17 | 1998 | 34 | |
| 18 | 1974 | 33 | |
| 19 | 2005 | 30 | |
| 20 | 2006 | 30 |
About Paul L. Debbage
Paul L. Debbage is a scholar working on Biomaterials, Molecular Biology, Neurology, Radiology, Nuclear Medicine and Imaging and Pharmaceutical Science, having authored 75 papers that have together received 2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (13 papers), Glycosylation and Glycoproteins Research (10 papers), Lanthanide and Transition Metal Complexes (8 papers), Barrier Structure and Function Studies (6 papers), Advanced Drug Delivery Systems (5 papers), Cancer Cells and Metastasis (5 papers), Angiogenesis and VEGF in Cancer (5 papers) and MRI in cancer diagnosis (4 papers). The work is most often cited by research in Biomaterials (283 citations), Drug Discovery (5 citations), Pharmaceutical Science (112 citations), Structural Biology (34 citations) and Otorhinolaryngology (62 citations). Paul L. Debbage has collaborated with scholars based in Austria, Germany and Switzerland. Frequent co-authors include Werner Rudolf Jaschke, Ira Skvortsova, Sergej Skvortsov, Peter H. Lukas, Christian Kremser, Vinod Kumar, Hans‐Joachim Gabius, Peter Hutzler, Margit Pavelka and Thomas Gneiting. Their work appears in journals such as Histochemistry and Cell Biology, Radiotherapy and Oncology, Seminars in Cancer Biology, Molecular Imaging and Biology and Acta Histochemica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.